E. Ohman J:or Asset Management AB
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2009396
STOCKHOLM, V7
Position in VRTX
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$4,382,648
+$442,826 QoQ
Shares Held
8,823
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#494
of 1,705 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026E. Ohman J:or Asset Management AB holds $53,160,442 across 15 Biotechnology names. VRTX ranks #2 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
304,611 | $25,949,811 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
8,823 | $4,382,648 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
160,000 | $4,115,200 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
385,000 | $3,780,700 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
85,777 | $3,680,691 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
45,794 | $2,882,274 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,840 | $2,394,393 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,584 | $1,379,921 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,382,648 | 8,823 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $3,939,822 | 8,823 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $4,090,667 | 9,023 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $4,120,052 | 10,520 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $4,683,504 | 10,520 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $5,570,581 | 11,490 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $4,727,698 | 11,740 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $4,794,974 | 10,310 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $5,184,043 | 11,060 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,389,105 | 10,500 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,068,900 | 10,000 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $4,138,106 | 11,900 | Shares | Sole | 2024-02-06 | |
| 2022-06-30 | $3,127,869 | 11,100 | Shares | Sole | 2024-04-05 | |
| 2022-03-31 | $2,948,961 | 11,300 | Shares | Sole | 2024-04-05 | |
| 2021-12-31 | $2,810,880 | 12,800 | Shares | Sole | 2024-04-05 | |
| 2021-09-30 | $2,158,541 | 11,900 | Shares | Sole | 2024-04-05 | |
| 2021-06-30 | $2,399,397 | 11,900 | Shares | Sole | 2024-04-05 | |
| 2021-03-31 | $37,401,604 | 174,050 | Shares | Sole | 2024-04-05 | |
| 2020-12-31 | $2,552,472 | 10,800 | Shares | Sole | 2024-04-05 | |
| 2020-09-30 | $2,938,896 | 10,800 | Shares | Sole | 2024-04-05 | |
| 2020-06-30 | $2,903,100 | 10,000 | Shares | Sole | 2024-04-05 | |
| 2020-03-31 | $2,117,755 | 8,900 | Shares | Sole | 2024-04-05 | |
| No filing history on record for this holder in this stock. | ||||||